- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Sunshine Biopharma stock hits 52-week low at $2.3 amid sharp decline | 3 | Investing.com | ||
| Fr | Sunshine Biopharma-Aktie erreicht 52-Wochen-Tief bei 2,3 US-Dollar | 2 | Investing.com Deutsch | ||
| SUNSHINE BIOPHARMA Aktie jetzt für 0€ handeln | |||||
| 07.11. | Sunshine Biopharma Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.11. | Sunshine Biopharma reports Q3 results | 1 | Seeking Alpha | ||
| 06.11. | Sunshine Biopharma, Inc.: Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% | 335 | ACCESSWIRE | FORT LAUDERDALE, FL / ACCESSWIRE / November 6, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic... ► Artikel lesen | |
| 05.11. | Sunshine Biopharma Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 23.10. | Sunshine Biopharma Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 12.10. | Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in September | 1 | MarketBeat | ||
| 26.09. | Sunshine Biopharma, Inc.: Sunshine Biopharma Launches Two New Generic Prescription Drugs | 134 | ACCESSWIRE | FORT LAUDERDALE, FL / ACCESSWIRE / September 26, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of... ► Artikel lesen | |
| 10.09. | Sunshine Biopharma meets Nasdaq compliance requirements | 4 | Investing.com | ||
| 10.09. | Sunshine Biopharma, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 04.09. | Sunshine Biopharma reports potential SARS-CoV-2 treatment | 3 | Investing.com | ||
| 04.09. | Sunshine Biopharma, Inc.: Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry | 181 | ACCESSWIRE | Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10), targeting SARS-CoV-2 papain-like protease (PLpro) with both... ► Artikel lesen | |
| 27.08. | Pre-market Movers: Trinity Biotech, Smart for Life, Society Pass, Addex Therapeutics, Sunshine Biopharma | 467 | AFX News | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 06.55 A.M. ET).In the Green Trinity Biotech plc (TRIB) is up... ► Artikel lesen | |
| 26.08. | Sunshine Biopharma, Inc.: Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada | 312 | ACCESSWIRE | FORT LAUDERDALE, FL / ACCESSWIRE / August 26, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic... ► Artikel lesen | |
| 20.08. | Sunshine Biopharma, Inc - 10-Q/A, Quarterly Report | 2 | SEC Filings | ||
| 19.08. | Sunshine Biopharma, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 19.08. | Sunshine Biopharma, Inc.: Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% | 271 | ACCESSWIRE | FORT LAUDERDALE, FL / ACCESSWIRE / August 19, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic... ► Artikel lesen | |
| 16.08. | Sunshine Biopharma, Inc - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 12.08. | Sunshine Biopharma enacts 1-for-20 reverse stock split | 1 | Investing.com |
Seite:
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 8,600 | -3,91 % | Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported... ► Artikel lesen | |
| CASSAVA SCIENCES | 26,760 | +4,53 % | Cassava Sciences updates on Phase 3 Alzheimer's trial ahead of key readout | ||
| ORAMED PHARMACEUTICALS | 2,224 | +5,20 % | Oramed Pharmaceuticals Inc.: Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt | NEW YORK, Oct. 7, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ("Oramed"), a clinical-stage pharmaceutical company focused on the development of oral drug delivery... ► Artikel lesen | |
| ROCKET LAB USA | 18,100 | +0,11 % | Rocket Lab USA, Inc: Rocket Lab Schedules Next Launch for Constellation Operator Kinéis | The mission will be the third of five dedicated Electron launches booked by the French Internet-of-Things constellation operator
Rocket Lab USA, Inc ("Rocket Lab" or the "Company") (Nasdaq: RKLB)... ► Artikel lesen | |
| LIPOCINE | 5,040 | -1,95 % | Lipocine Inc.: Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2024 | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment... ► Artikel lesen | |
| BOIRON | 30,650 | -0,33 % | BOIRON: EVOLUTION OF GOVERNANCE | July 3rd, 2024
The Board of Directors of Laboratoires BOIRON, meeting today under the chairmanship of Thierry BOIRON, has enacted an evolution of the Group's governance.
In this context, Thierry... ► Artikel lesen | |
| ALLERGY THERAPEUTICS | 0,058 | 0,00 % | Allergy Therapeutics annual loss narrows thanks to reduced expenses | ||
| MEDICINOVA | 1,760 | +10,00 % | MediciNova, Inc.: MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver | LA JOLLA, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| HARROW | 39,000 | -9,01 % | Pre-market Movers: California BanCorp, Harrow, Inc., Quantum Computing, BTC Digital, Calidi Biotherapeutics | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.15 A.M. ET).In the Green California BanCorp. (BCAL) is up over 33% at $23.01.
Quantum... ► Artikel lesen | |
| ESSA PHARMA | 1,720 | -2,27 % | ESSA Pharma: NBC-Anlegerclub feiert schnelle +23% Rendite! | Der No Brainer Club (NBC) hat erneut sein Gespür für unterbewertete Biotech-Perlen unter Beweis gestellt. Mit ESSA Pharma konnten Mitglieder in diesem fulminanten Biotech-Herbst innerhalb weniger Tage... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,440 | -2,84 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Anaphylm (epinephrine) Sublingual Film pre-NDA meeting scheduled for fourth quarter 2024AQST-108 (epinephrine) Topical Gel pre-IND meeting scheduled for fourth quarter 2024Libervant® (diazepam) Buccal... ► Artikel lesen | |
| SHINECO | 2,460 | -13,38 % | SHINECO, INC. - 10-Q, Quarterly Report | ||
| CYANOTECH | 0,260 | 0,00 % | Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2025 | KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results... ► Artikel lesen | |
| REVIVA PHARMACEUTICALS | 1,125 | -7,02 % | Reviva Pharmaceuticals: Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights | - 108 patients have completed 1-year of treatment in 1-year open-label extension (OLE) trial - - Vocal biomarker speech latency data from RECOVER trial reinforce brilaroxazine's improvement on negative... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 1,070 | -10,83 % | Cumberland Pharma-Aktie erreicht 52-Wochen-Tief bei 1,07 US-Dollar |
Das Unternehmen SUNSHINE BIOPHARMA INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 2,330 Euro und damit -8,98 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SUNSHINE BIOPHARMA INC finden Sie auf Wallstreet Online.
